英文别名:
Rimtuzalcap;USO2D5J77R;Rimtuzalcap [INN];Rimtuzalcap [USAN];WHO 11140;compound 1 (US9975886B1);4-PYRIMIDINAMINE, N-(4,4-DIFLUOROCYCLOHEXYL)-2-(3-METHYL-1H-PYRAZOL-1-YL)-6-(4-MORPHOLINYL)-;2167246-24-2;D11891;CAD1883;MS-26171;EX-A5743;CS-0116077;SCHEMBL19686931;AKOS040759848;GTPL12649;Rimtuzalcap [USAN:INN];UNII-USO2D5J77R;N-(4,4-difluorocyclohexyl)-2-(3-methylpyrazol-1-yl)-6-morpholin-4-ylpyrimidin-4-amine;CHEMBL4650330;N-(4,4-DIFLUOROCYCLOHEXYL)-2-(3-METHYL-1H-PYRAZOL-1-YL)-6-MORPHOLINOPYRIMIDIN-4-AMINE;HY-109160;Rimtuzalcap (USAN/INN);DA-67210;compound 1 [US9975886B1];Rimtuzalcap?;OVLIDRAJVMUEMC-UHFFFAOYSA-N;CAD-1883;
Inchi:
1S/C18H24F2N6O/c1-13-4-7-26(24-13)17-22-15(21-14-2-5-18(19,20)6-3-14)12-16(23-17)25-8-10-27-11-9-25/h4,7,12,14H,2-3,5-6,8-11H2,1H3,(H,21,22,23)